Perched on the cliffs of Torrey Pines in San Diego, investors, CEOs, and scientists this week debated whether U.S. biotechs are losing ground to China. Meanwhile, across the Pacific, Chinese companies were busy inking deals.
‘It’s a wake-up call’: US biotechs discuss why we’ve fallen behind China
